VALENSCION
Idera Pharmaceuticals, Inc.
Mark For: VALENSCION™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88056116 |
| Mark Literal Elements | VALENSCION |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2019-09-03 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Michael J. Bevilacqua, Esquire |
| Attorney Docket Number | 475.08.512 |
| Law Office Assigned | L60 |
| Employee Name | RICHARDS, LESLIE L |
Timeline
| 2018-07-27 | Application Filed |
| 2019-07-09 | Published |
| 2019-07-09 | Published for Opposition |
| 2019-09-03 | Location: INTENT TO USE SECTION |
| 2019-09-03 | Status: Live/Pending |
| 2019-09-03 | Transaction Date |
| 2021-03-03 | Status: A third request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Idera Pharmaceuticals, Inc. |
| Address | 505 Eagleview Boulevard, Suite 212 Exton, PENNSYLVANIA UNITED STATES 19341 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | JPEG | 2018-07-27 |
 TEAS RF New Application | MULTI | 2018-07-27 |
| XSearch Search Summary | XML | 2018-11-14 |
| Offc Action Outgoing | MULTI | 2018-11-20 |
| XSearch Search Summary | XML | 2018-11-20 |
| Response to Office Action | XML | 2019-05-14 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2019-05-15 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-05-23 |
| Notice of Publication | XML | 2019-06-19 |
| Notification Of Notice of Publication | XML | 2019-06-19 |
| OG Publication Confirmation | XML | 2019-07-09 |
| Notice of Allowance | XML | 2019-09-03 |
| Extension of Time to File SOU | APPLICATION/XML | 2020-03-03 |
| ITU Extension Approval | APPLICATION/XML | 2020-03-05 |
| ITU Unit Action | MULTI | 2020-03-05 |
| Extension of Time to File SOU | APPLICATION/XML | 2020-09-03 |
| ITU Extension Approval | XML | 2020-09-05 |
| ITU Unit Action | MULTI | 2020-09-05 |
| Change Address or Representation Form | XML | 2021-02-10 |
| Extension of Time to File SOU | XML | 2021-03-03 |
| ITU Extension Approval | APPLICATION/XML | 2021-03-05 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2021-03-05 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals for use in the treatment of viral infection, bacterial infection, asthma, allergies, cancer, transplant rejection, inflammatory diseases and disorders, immune diseases and disorders, hereditary diseases and disorders, namely, metabolic, endocrine, neurologic and cardiovascular diseases or disorders, and auto immune diseases and disorders; pharmaceuticals for use in the treatment of T-cell and B-cell leukemias and lymphomas; medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; medical therapeutic preparations, namely, small molecule chemicals aimed at inhibiting cellular proteins
IC 042. US 100 101. G & S: Medical research; scientific research; biological research; chemical research; pharmaceutical research services; pharmaceutical research and development; product research and development; medical and scientific research in the area of oligonucleotides or chemical products; medical and scientific research in the area of the structure-based drug design; biological and chemical research in the field of immunology, virology, oncology and hereditary diseases; medical and scientific research in the area of small molecule chemicals aimed at inhibiting cellular proteins for use as therapeutic agents; pharmaceutical research and development in the field of infectious diseases and disorders, cancer, viral diseases and disorders, inflammatory diseases and disorders, immunological diseases and disorders, autoimmune diseases and disorders, hereditary diseases and disorders, and cardiovascular diseases and disorders
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals for use in the treatment of viral infection, bacterial infection, asthma, allergies, cancer, transplant rejection, inflammatory diseases and disorders, immune diseases and disorders, hereditary diseases and disorders, namely, metabolic, endocrine, neurologic and cardiovascular diseases or disorders, and auto immune diseases and disorders; pharmaceuticals for use in the treatment of T-cell and B-cell leukemias and lymphomas; medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; medical therapeutic preparations, namely, small molecule chemicals aimed at inhibiting cellular proteins |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-05 | |
| TEAS EXTENSION RECEIVED | 2021-03-03 | |
| EXTENSION 3 GRANTED | 2021-03-03 | 98765 |
| EXTENSION 3 FILED | 2021-03-03 | 98765 |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2021-02-10 | |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-02-10 | |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-02-10 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-02-10 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-02-10 | |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-02-10 | 88888 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-09-05 | |
| TEAS EXTENSION RECEIVED | 2020-09-03 | |
| EXTENSION 2 GRANTED | 2020-09-03 | 98765 |
| EXTENSION 2 FILED | 2020-09-03 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-03-05 | |
| TEAS EXTENSION RECEIVED | 2020-03-03 | |
| EXTENSION 1 GRANTED | 2020-03-03 | 98765 |
| EXTENSION 1 FILED | 2020-03-03 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-09-03 | |
| PUBLISHED FOR OPPOSITION | 2019-07-09 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-07-09 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-06-19 | |
| ASSIGNED TO LIE | 2019-06-04 | 70468 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-05-22 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-05-14 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-05-14 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-14 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-11-20 | 6325 |
| NON-FINAL ACTION WRITTEN | 2018-11-20 | 76584 |
| NON-FINAL ACTION E-MAILED | 2018-11-20 | 6325 |
| ASSIGNED TO EXAMINER | 2018-11-14 | 76584 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-08-02 | |
| NEW APPLICATION ENTERED IN TRAM | 2018-07-31 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 